338 related articles for article (PubMed ID: 12511537)
1. Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis.
Kurisu S; Ozono R; Oshima T; Kambe M; Ishida T; Sugino H; Matsuura H; Chayama K; Teranishi Y; Iba O; Amano K; Matsubara H
Hypertension; 2003 Jan; 41(1):99-107. PubMed ID: 12511537
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension.
Ichihara S; Senbonmatsu T; Price E; Ichiki T; Gaffney FA; Inagami T
Circulation; 2001 Jul; 104(3):346-51. PubMed ID: 11457756
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation.
Tsutsumi Y; Matsubara H; Masaki H; Kurihara H; Murasawa S; Takai S; Miyazaki M; Nozawa Y; Ozono R; Nakagawa K; Miwa T; Kawada N; Mori Y; Shibasaki Y; Tanaka Y; Fujiyama S; Koyama Y; Fujiyama A; Takahashi H; Iwasaka T
J Clin Invest; 1999 Oct; 104(7):925-35. PubMed ID: 10510333
[TBL] [Abstract][Full Text] [Related]
4. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.
Gohlke P; Pees C; Unger T
Hypertension; 1998 Jan; 31(1 Pt 2):349-55. PubMed ID: 9453327
[TBL] [Abstract][Full Text] [Related]
5. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression.
Tsutsumi Y; Matsubara H; Ohkubo N; Mori Y; Nozawa Y; Murasawa S; Kijima K; Maruyama K; Masaki H; Moriguchi Y; Shibasaki Y; Kamihata H; Inada M; Iwasaka T
Circ Res; 1998 Nov; 83(10):1035-46. PubMed ID: 9815151
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of cyclic GMP production via AT2 and B2 receptors in the pressure-overloaded aorta after banding.
Hiyoshi H; Yayama K; Takano M; Okamoto H
Hypertension; 2004 Jun; 43(6):1258-63. PubMed ID: 15123575
[TBL] [Abstract][Full Text] [Related]
8. Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism.
Takata H; Yamada H; Kawahito H; Kishida S; Irie D; Kato T; Wakana N; Miyagawa S; Fukui K; Matsubara H
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):311-20. PubMed ID: 23736171
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice.
Abadir PM; Carey RM; Siragy HM
Hypertension; 2003 Oct; 42(4):600-4. PubMed ID: 12953015
[TBL] [Abstract][Full Text] [Related]
10. Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis.
Li P; Kondo T; Numaguchi Y; Kobayashi K; Aoki M; Inoue N; Okumura K; Murohara T
Hypertension; 2008 Feb; 51(2):252-8. PubMed ID: 18086946
[TBL] [Abstract][Full Text] [Related]
11. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
[TBL] [Abstract][Full Text] [Related]
12. Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats.
Katoh M; Egashira K; Usui M; Ichiki T; Tomita H; Shimokawa H; Rakugi H; Takeshita A
Circ Res; 1998 Oct; 83(7):743-51. PubMed ID: 9758645
[TBL] [Abstract][Full Text] [Related]
13. Potent antihypertrophic effect of the bradykinin B2 receptor system on the renal vasculature.
Tsuchida S; Miyazaki Y; Matsusaka T; Hunley TE; Inagami T; Fogo A; Ichikawa I
Kidney Int; 1999 Aug; 56(2):509-16. PubMed ID: 10432390
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries.
Batenburg WW; Garrelds IM; Bernasconi CC; Juillerat-Jeanneret L; van Kats JP; Saxena PR; Danser AH
Circulation; 2004 May; 109(19):2296-301. PubMed ID: 15117835
[TBL] [Abstract][Full Text] [Related]
15. Farnesoid X receptor regulates vasoreactivity via Angiotensin II type 2 receptor and the kallikrein-kinin system in vascular endothelial cells.
Zhang R; Ran H; Peng L; Zhang Y; Shen W; Sun T; Cao F; Chen Y
Clin Exp Pharmacol Physiol; 2016 Mar; 43(3):327-34. PubMed ID: 26710942
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice.
Trabold F; Pons S; Hagege AA; Bloch-Faure M; Alhenc-Gelas F; Giudicelli JF; Richer-Giudicelli C; Meneton P
Hypertension; 2002 Jul; 40(1):90-5. PubMed ID: 12105144
[TBL] [Abstract][Full Text] [Related]
18. Expression and distribution of NOS1 and NOS3 in the myocardium of angiotensin II-infused rats.
Tambascia RC; Fonseca PM; Corat PD; Moreno H; Saad MJ; Franchini KG
Hypertension; 2001 Jun; 37(6):1423-8. PubMed ID: 11408389
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells.
Jin XQ; Fukuda N; Su JZ; Lai YM; Suzuki R; Tahira Y; Takagi H; Ikeda Y; Kanmatsuse K; Miyazaki H
Hypertension; 2002 May; 39(5):1021-7. PubMed ID: 12019286
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of bradykinin B2-receptor mRNA in the heart in pressure-overload cardiac hypertrophy in the rat.
Yayama K; Matsuoka S; Nagaoka M; Shimazu E; Takano M; Okamoto H
Biochem Pharmacol; 2003 Mar; 65(6):1017-25. PubMed ID: 12623134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
